Antibiotic resistance among clinically important Gram-positive bacteria in the UK

Journal of Hospital Infection

Volumn 40, Issue 1, 1998, Pages 17-26

  Johnson, A P ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

Antibiotic resistance; Enterococci; Staphylococcus aureus; Streptococcus pneumoniae

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GLYCOPEPTIDE; LINCOSAMIDE; MACROLIDE; METICILLIN; PENICILLIN G; PSEUDOMONIC ACID; QUINOLONE; RIFAMPICIN; STREPTOGRAMIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROCOCCUS; EPIDEMIC; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TOPICAL DRUG ADMINISTRATION;

EID: 0031787673     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(98)90020-2     Document Type: Review

References (77)

1. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University workshop. New Engl J Med 1994; 330: 1247-1251.
2. Marples RR, Reith S. Methicillin-resistant Staphylococcus aureus in England and Wales. CDR Rev 1992; 2: R25-R29.
3. Chambers HF. Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997; 10: 781-791.
4. Kerr S, Kerr GE, Mackintosh CA, Marples RR. A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales. J Hosp Infect 1990; 16: 35-48.
5. Richardson JF, Reith S. Characterisation of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J Hosp Infect 1993; 25: 45-52.
6. Cox RA, Conquest C, Mallaghan C, Marples RR. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phagetype (EMRSA-16). J Hosp Infect 1995; 29: 87-106.
7. Anon. Epidemic methicillin resistant Staphylococcus aureus. CDR 1997; 7: 191.
8. Duckworth G, Heathcock R. Guidelines on the control of methicillin-resistant Staphylococcus aureus in the community. J Hosp Infect 1995; 31: 1-12.
9. Høiby N, Jarløv JO, Kemp M, Tvede M, Bangsborg JM, Kjerulf A, Pers C, Hansen H. Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 1997; 349: 167-169.
10. Mackintosh CA, Marples RR, Kerr GE, Bannister BA. Surveillance of methicillin-resistant Staphylococcus aureus in England and Wales 1989-1990. J Hosp Infect 1991; 18: 279-292.
11. Speller DCE, Johnson AP, James D, Marples RR, Charlett A, George RC. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet 1997; 350: 323-325.
12. Johnson AP, James D. Continuing increase in invasive methicillin-resistant infection. Lancet 1997; 350: 1710.
13. Eltringham I. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1997; 35: 1-8.
14. Marples RR, Speller DCE, Cookson BD. Prevalence of mupirocin resistance in Staphylococcus aureus. J Hosp Infect 1995; 29: 153-161.
15. Woodford N, Johnson AP, Morrison D, Speller DCE. Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995; 8: 585-615.
16. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136.
17. Anon. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. Morbid Mortal Weekly Rep 1997; 46: 765-766.
18. Anon. Detecting vancomycin intermediate Staphylococcus aureus. CDR 1997; 47: 417-420.
19. Baquero F. Gram-positive resistance: challenges for the development of new antibiotics. J Antimicrob Chemother 1997; 39 (Suppl. A): 1-6.
20. Andrews JM, Ashby JP, Jevons G, Wise R. Surveillance of Gram positive pathogens in the UK (1996). Proceedings of the Fourth Conference of the Federation of Infection Societies, 1997; Abstract P35.
21. Burnie JP, Loudon KW. Ciprofloxacin-resistant Staphylococcus epidermidis and hands. Lancet 1997; 349: 649.
22. Goldstein FW, Coutrot A, Sieffer A, Acar JF. Percentages and distributions of teicoplanin-and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother 1990; 34: 899-900.
23. Kislak JW, Razavi LMB, Daly AK, Finland M. Susceptibility of pneumococci to nine antibiotics. Am J Med Sci 1965; 250: 261-268.
24. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967; ii: 264-265.
25. Howes VJ, Mitchell RG. Meningitis due to a relatively penicillin-resistant pneumococcus. Br Med J 1976; i: 996.
26. Meers PD, Matthews RB. Multiply-resistant pneumococcus. Lancet 1978; ii: 219.
27. Shanson DC, Rees T, Sinclair L. Ear infection due to penicillin-resistant pneumococcus in immunodeficient child. Lancet 1979; ii: 956.
28. Johnson AP, Speller DCE, George RC, Warner M, Domingue G, Efstratiou A. Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. Br Med J 1996; 312: 1454-1456.
29. Aszkenasy OM, George RC, Begg NT. Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992. CDR Rev 1995; 5: R45-R50.
30. Anon. Antimicrobial resistance of pneumococci isolated from blood and cerebrospinal fluid 1993 and 1994. CDR 1995; 5: 187-188.
31. Laurichesse H, Grimaud O, Kaye P, Johnson AP, George RC, Miller E. Pneumococcal bacteraemia and meningitis in England and Wales, 1993-1995. Comm Dis Publ Hlth 1998 1: 22-27.
32. Goldsmith CE, Moore JE, Murphy PG. Prevalence of antibiotic resistance in pneumococci. Br Med J 1996; 313: 820.
33. Boswell TCJ, Frodsham D, Nye KJ, Smith EG. Antibiotic resistance and serotypes of Streptococcus pneumoniae at Birmingham Public Health Laboratory, 1989-94. J Infect 1996; 33: 17-22.
34. Nair P. Incidence of decreased sensitivity of Streptococcus pneumoniae from clinical isolates. J Clin Pathol 1988; 41: 720-721.
35. Felmingham D, Gruneburg RN and the Alexander Project Group. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project. J Antimicrob Chemother 1996 38 (Suppl. A): 1-57.
36. Wilson P, Lewis D, Jenks P, Hoque S. Prevalence of antibiotic resistance in pneumococci. Br Med J 1996; 313: 819-820.
37. Ridgway EJ, Allen KD, Galloway A, Rigby A, O'Donoghue M. Penicillin-resistant pneumococci in a Merseyside hospital. J Hosp Infect 1991; 17: 15-23.
38. Allen KD, Anson JJ. Prevalence of antibiotic resistance in pneumococci. Br Med J 1996; 313: 820.
39. Klugman K, Goldstein F, Kohno S, Baquero F. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clin Microbiol Infect 1997; 3 (Suppl. 1): S48-S60.
40. Käyhty H, Eskola J. New vaccines for the prevention of pneumococcal infections. Emerging Infect Dis 1996; 2: 289-298.
41. George RC, Ball LC, Johnson AP, Efstratiou A. Reference laboratory experience of antibiotic resistant pneumococci in the UK 1987-1992. In Pathogenic Streptococci: Present and Future (ed. Totalian A) 1994; Lancer Publication, St Petersburg, Russia.
42. George RC, Johnson AP, Speller DCE, Efstratiou A, Broughton K, Patel BC. Serogroups/types and antibiotic resistance of referred isolates of Streptococcus pneumoniae: 1993 to 1995. CDR Rev 1997; 7: R159-R164.
43. Coffey TJ, Dowson CG, Daniels M, Spratt BG. Genetics and molecular biology of β-lactam-resistant pneumococci. Microb Drug Res 1995; 1: 29-34.
44. Munoz R, Coffey TJ, Daniels M, Dowson CG, Laible G, Casal J, Hackenbeck R, Jacobs M, Musser JM, Spratt BG. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164: 302-306.
45. Colman G, Cooke EM, Cookson BD, Cooper PG, Efstratiou A, George RC. Pneumococci causing invasive disease in Britain 1982-1990. J Med Microbiol 1997; 46: 1-11.
46. Dowson CG, Hutchison A, Brannigan JA, George RC, Hansman D, Linares J, Tomasz A, Maynard-Smith J, Spratt BG. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1989; 86: 8842-8846.
47. Hall LMC, Whiley RA, Duke B, George RC, Efstratiou A. Genetic relatedness within and between serotypes of Streptotoccus pneumoniae from the United Kingdom: Analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns. J Clin Microbiol 1996; 34: 853-859.
48. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990; 3: 46-55.
49. Eliopoulos GM. Antibiotic resistance in Enterococcus species: an update. Curr Clin Topic Infect Dis 1996; 16: 21-51.
50. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; i: 57-58.
51. Uttley AHC, George RC. Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AJ, Fitch LE, Heptonstall J. High-level vancomycin-resistant enterococci causing hospital infection. Epidemiol Infect 1989; 103: 173-181.
52. Woodford N, Morrison D, Johnson AP, Briant V, George RC, Cookson B. Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31: 653-658.
53. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-161.
54. Anon. Vancomycin resistant enterococci in hospitals in the United Kingdom - 1995. CDR 1996; 6: 267.
55. Cookson B, Morrison D, Marples R. Nosocomial Gram-positive infection. J Med Microbiol 1997; 46: 439-442.
56. Anon. Vancomycin resistant enterococci in hospitals in the United Kingdom. CDR 5: 283-284.
57. Leclercq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997; 24: 545-556.
58. Korten V, Murray BE. The nosocomial transmission of enterococci. Curr Opinion Infect Dis 1993; 6: 498-505.
59. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, Eisner W, Warren S, Kreiswirth B. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342: 76-79.
60. Rice LB. The theoretical origin of vancomycin-resistant enterococci. Clin Microbiol Newslett 1996; 17: 189-192.
61. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994; 34: 515-528.
62. Bates J, Jordens JZ, Griffiths DT. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994; 34: 507-514.
63. Klare I, Heier H, Claus R, Reisbrodt R, Witte W. VanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 1995; 125: 165-172.
64. Aarestrup FM. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Resist 1995; 1: 255-257.
65. MacGowan AP, McLaughlin J. Antibiotic resistance of Listeria monocytogenes. Lancet 1990; 336: 513-514.
66. MacGowan AP, Holt HA, Bywater MJ, Reeves DS. In vitro antimicrobial susceptibility of Listeria monocytogenes isolated in the UK and other Listeria species. Eur J Clin Microbiol Infect Dis 1990; 9: 767-770.
67. Johnson AP, McLauchlin J, Shah S, Warner M. Antimicrobial susceptibility of Listeria isolates obtained from 515 cases of human listeriosis in the UK between 1990-95. Lett Med Microbiol 1996; 5: 1-7.
68. Cartwright K, Logan M, McNulty C, Harrison S, George R, Efstratiou A, McEvoy M, Begg N. A cluster of cases of necrotizing fasciitis in Gloucestershire. Epidemiol Infect 1995; 115: 387-397.
69. Anon. Invasive group A streptococcal infections in Gloucestershire. CDR 1994; 4: 43.
70. Waldvogel F. New insights into septic and toxic diseases produced by Staphylococcus aureus. Curr Opinion Infect Dis 1995; 8: S3-S6.
71. Johnson AP. The pathogenicity of enterococci. J Antimicrob Chemother 1994; 33: 1083-1089.
72. Bouanchaud DH. In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin. J Antimicrob Chemother 1997; 39 (Suppl. A): 15-21.
73. Johnson AP, Warner M, Speller DCE. In vitro activity of quinupristin/dalfopristin (Synercid) against isolates of Streptococcus pneumoniae, Staphylococcus aureus and Enterococcus spp. J Antimicrob Chemother 1997; 40: 604-605.
74. Appelbaum PC. New prospects for antibacterial agents against multidrug-resistant pneumococci. Microb Drug Res 1995; 1: 43-48.
75. Ford CW, Hamel JC, Stapert D, Moerman JK, Hutchinson DK, Barbachyn MR, Zurenko GE. Oxazolidinones: New antibacterial agents. Trends Microbiol 1997; 5: 196-200.
76. Jamjian C, Bidenbach DJ, Jones RN. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004. Antimicrob Agents Chemother 1997; 41: 454-459.
77. Woodford N, Palepou M-F, Johnson AP, Chadwick PR, Bates J. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Lancet 1997; 350: 738.